Similar articles for PMID: 18052574

Year	Number of Results
1981	1
1996	1
1997	1
1999	1
2000	2
2001	13
2002	6
2003	15
2004	27
2005	26
2006	20
2007	21
2008	25
2009	19
2010	15
2011	22
2012	11
2013	20
2014	11
2015	5
2016	4
2017	6
2018	11
2019	11
2020	12
2021	17
2022	15
2023	4
2024	0

1

Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study.

Saddichha S, Manjunatha N, Ameen S, Akhtar S. Saddichha S, et al. J Clin Psychiatry. 2007 Nov;68(11):1793-8. doi: 10.4088/jcp.v68n1120. J Clin Psychiatry. 2007. PMID: 18052574 Clinical Trial.

2

Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.

Saddichha S, Ameen S, Akhtar S. Saddichha S, et al. J Clin Psychopharmacol. 2008 Feb;28(1):27-31. doi: 10.1097/jcp.0b013e3181602fe6. J Clin Psychopharmacol. 2008. PMID: 18204337 Clinical Trial.

3

A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.

Perez-Iglesias R, Crespo-Facorro B, Amado JA, Garcia-Unzueta MT, Ramirez-Bonilla ML, Gonzalez-Blanch C, Martinez-Garcia O, Vazquez-Barquero JL. Perez-Iglesias R, et al. J Clin Psychiatry. 2007 Nov;68(11):1733-40. doi: 10.4088/jcp.v68n1113. J Clin Psychiatry. 2007. PMID: 18052567 Clinical Trial.

4

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.

Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I; IC-SOHO Study Group. Dossenbach M, et al. J Clin Psychiatry. 2004 Mar;65(3):312-21. J Clin Psychiatry. 2004. PMID: 15096069

5

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J. Crespo-Facorro B, et al. J Clin Psychiatry. 2006 Oct;67(10):1511-21. doi: 10.4088/jcp.v67n1004. J Clin Psychiatry. 2006. PMID: 17107241 Clinical Trial.

6

Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.

Volavka J, Czobor P, Cooper TB, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Lieberman JA. Volavka J, et al. J Clin Psychiatry. 2004 Jan;65(1):57-61. doi: 10.4088/jcp.v65n0109. J Clin Psychiatry. 2004. PMID: 14744169 Clinical Trial.

7

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.

Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD. Basson BR, et al. J Clin Psychiatry. 2001 Apr;62(4):231-8. doi: 10.4088/jcp.v62n0404. J Clin Psychiatry. 2001. PMID: 11379836 Clinical Trial.

8

Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.

Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, García-Portilla MP, Fernández I, Hernández G; EIRE Study Group. Bobes J, et al. Schizophr Res. 2003 Jul 1;62(1-2):77-88. doi: 10.1016/s0920-9964(02)00431-0. Schizophr Res. 2003. PMID: 12765747

9

Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.

Dossenbach M, Pecenak J, Szulc A, Irimia V, Anders M, Logozar-Perkovic D, Peciukaitiene D, Kotler M, Smulevich AB, West TM, Lowry AJ, Treuer T. Dossenbach M, et al. J Clin Psychiatry. 2008 Dec;69(12):1901-15. Epub 2008 Sep 9. J Clin Psychiatry. 2008. PMID: 19012820

10

Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naïve population.

Perez-Iglesias R, Crespo-Facorro B, Martinez-Garcia O, Ramirez-Bonilla ML, Alvarez-Jimenez M, Pelayo-Teran JM, Garcia-Unzueta MT, Amado JA, Vazquez-Barquero JL. Perez-Iglesias R, et al. Schizophr Res. 2008 Feb;99(1-3):13-22. doi: 10.1016/j.schres.2007.10.022. Epub 2007 Dec 3. Schizophr Res. 2008. PMID: 18053689 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

309 results

Results by year